Novartis obtains rights to use Parvus' Navacim to develop products for T1D - Pharmaceutical Technology
Galvus Met 50mg 1000mg Tablets (Vildagliptin And Metformin HCI Tablet), Novartis India Ltd, Non prescription
Galvus Met 50/500 mg Tablet 15'S: Buy medicine online for best price | Netmeds
Eris buys diabetes brand from Novartis - Times of India
AJA Pharma, Novartis to launch SAR 50 mln production line
Galvus® Met 50mg/500mg Film-Coated Tablets
Novartis to prioritise U.S. market, unfazed by drug pricing pushback | Reuters
Stock Market | FinancialContent Business Page
Cipla acquires anti-diabetes brand in India from Novartis - Times of India
Novartis - Wikipedia
Novartis sues Biocon over anti-diabetes drug vildagliptin: Bitter pill? – Spicyip
NOVARTIS NovoMix 30 Penfill at Rs 2000/box | Insulin Pen in Anantapur | ID: 2849516314512
Top 20 Diabetes Drugs 2017
Cipla Signs Licence Agreement With Novartis Ag To Manufacture And Market Type-2 Diabetes Medicine
Novartis Galvus tablets, Prescription, Treatment: Anti Diabetic
It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement. - The New York Times
Novartis division Sandoz to exclusively commercialize six products in US across key therapeutic areas
Galvus approved for type 2 diabetes monotherapy
NeoBiocon partners with Novartis to offer anti-diabetes drug Vildagliptin in UAE
Diabetes & Cholestrol Archives | Rocket Health
The world's top selling diabetes drugs - Pharmaceutical Technology
Novartis : Top 25 Pharma & BioPharma in 2020 | Contract Pharma
